Non-Invasive Monitoring Systems, Inc.
US ˙ OTCPK

Introduction

This page provides a comprehensive analysis of the known insider trading history of Adam Logal. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

Companies with Reported Insider Positions

The SEC filings indicate Adam Logal has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:NIMU / Non-Invasive Monitoring Systems, Inc. Director 0
US:OPK / OPKO Health, Inc. Sr. Vice President, CFO 616,662
US:XBIO / Xenetic Biosciences, Inc. Director 25,000
US:VBIV / VBI Vaccines Inc. Director 12,500
US:VXRT / Vaxart, Inc. Interim CFO, CAO and Treasurer 9,334
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by Adam Logal. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Purchases NIMU / Non-Invasive Monitoring Systems, Inc. - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in NIMU / Non-Invasive Monitoring Systems, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

NIMU / Non-Invasive Monitoring Systems, Inc. Insider Trades
Insider Sales NIMU / Non-Invasive Monitoring Systems, Inc. - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in NIMU / Non-Invasive Monitoring Systems, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

NIMU / Non-Invasive Monitoring Systems, Inc. Insider Trades
Insider Purchases OPK / OPKO Health, Inc. - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in NIMU / Non-Invasive Monitoring Systems, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
2019-05-09 OPK Logal Adam 100 2.0350 100 2.0350 204 53 2.4700 44 21.67
2019-05-09 OPK Logal Adam 3,150 2.0400 3,150 2.0400 6,426
2018-03-13 OPK Logal Adam 2,015 3.3950 2,015 3.3950 6,841
2018-03-13 OPK Logal Adam 50 3.4000 50 3.4000 170
2017-09-15 OPK Logal Adam 1,500 6.0300 1,500 6.0300 9,045
2015-09-14 OPK Logal Adam 100 9.9450 100 9.9450 994
2015-09-14 OPK Logal Adam 900 9.9500 900 9.9500 8,955

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

OPK / OPKO Health, Inc. Insider Trades
Insider Sales OPK / OPKO Health, Inc. - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in NIMU / Non-Invasive Monitoring Systems, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
2017-03-14 OPK Logal Adam 112,975 8.0697 112,975 8.0697 911,674 352 3.1800 -552,414 -60.59
2015-03-13 OPK Logal Adam 24 14.5600 24 14.5600 349
2015-03-13 OPK Logal Adam 576 14.6100 576 14.6100 8,415
2015-03-13 OPK Logal Adam 500 14.6150 500 14.6150 7,308
2015-03-13 OPK Logal Adam 38,888 14.6400 38,888 14.6400 569,320
2015-03-13 OPK Logal Adam 1,500 14.6450 1,500 14.6450 21,968
2013-02-01 OPK Logal Adam 10,000 6.7000 10,000 6.7000 67,000
2013-02-01 OPK Logal Adam 20,000 6.7100 20,000 6.7100 134,200
2013-02-01 OPK Logal Adam 20,000 6.7400 20,000 6.7400 134,800

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

OPK / OPKO Health, Inc. Insider Trades
Insider Purchases VXRT / Vaxart, Inc. - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in NIMU / Non-Invasive Monitoring Systems, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

VXRT / Vaxart, Inc. Insider Trades
Insider Sales VXRT / Vaxart, Inc. - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in NIMU / Non-Invasive Monitoring Systems, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

VXRT / Vaxart, Inc. Insider Trades
Insider Purchases XBIO / Xenetic Biosciences, Inc. - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in NIMU / Non-Invasive Monitoring Systems, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

XBIO / Xenetic Biosciences, Inc. Insider Trades
Insider Sales XBIO / Xenetic Biosciences, Inc. - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in NIMU / Non-Invasive Monitoring Systems, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

XBIO / Xenetic Biosciences, Inc. Insider Trades
Insider Trading History

This table shows the complete list of insider trades made by Adam Logal as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change
Share
Price
Tran
Value
Remaining
Value
2025-09-03 3 NIMU NON INVASIVE MONITORING SYSTEMS INC /FL/
Common Stock
0
2024-07-26 2024-07-24 4 OPK OPKO HEALTH, INC.
Common Stock
A - Award 437,500 616,662 244.19
2021-12-09 2021-12-07 4 XBIO Xenetic Biosciences, Inc.
Stock Options
A - Award 25,000 25,000
2021-02-22 2021-02-19 4 OPK OPKO HEALTH, INC.
Stock Option (Right to Buy)
A - Award 350,000 350,000
2020-12-08 2020-12-04 4 XBIO Xenetic Biosciences, Inc.
Stock Options
A - Award 25,000 25,000
2020-06-08 2020-06-04 4 OPK Opko Health, Inc.
Stock Option (Right to Buy)
A - Award 350,000 350,000
2019-12-06 2019-12-04 4 XBIO Xenetic Biosciences, Inc.
Stock Options
A - Award 25,000 25,000
2019-07-03 2019-07-01 4 OPK Opko Health, Inc.
Stock Option (Right to Buy)
A - Award 250,000 250,000
2019-05-10 2019-05-09 4 OPK Opko Health, Inc.
Common Stock
P - Purchase 3,150 179,162 1.79 2.04 6,426 365,490
2019-05-10 2019-05-09 4 OPK Opko Health, Inc.
Common Stock
P - Purchase 100 176,012 0.06 2.04 204 358,184
2018-11-30 2018-11-28 4 XBIO Xenetic Biosciences, Inc.
Stock Options
A - Award 25,000 25,000
2018-06-22 2018-06-21 4 OPK Opko Health, Inc.
Stock Option (Right to Buy)
A - Award 300,000 300,000
2018-06-18 2018-06-14 4 VBIV VBI Vaccines Inc/BC
Restricted Stock Units (RSUs)
M - Exercise -12,500 12,500 -50.00
2018-06-18 2018-06-14 4 VBIV VBI Vaccines Inc/BC
Common Shares, no par value per share
M - Exercise 12,500 37,500 50.00
2018-06-12 2018-06-08 4 OPK Opko Health, Inc.
Stock Option (Right to Buy)
M - Exercise -75,000 0 -100.00
2018-06-12 2018-06-08 4 OPK Opko Health, Inc.
Common Stock
F - Taxes -63,946 175,912 -26.66 4.26 -272,410 749,385
2018-06-12 2018-06-08 4 OPK Opko Health, Inc.
Common Stock
M - Exercise 75,000 239,858 45.49 3.43 257,250 822,713
2018-03-14 2018-03-13 4 OPK Opko Health, Inc.
Common Stock
P - Purchase 50 164,858 0.03 3.40 170 560,517
2018-03-14 2018-03-13 4 OPK Opko Health, Inc.
Common Stock
P - Purchase 2,015 164,808 1.24 3.40 6,841 559,523
2018-01-25 2018-01-23 4 VBIV VBI Vaccines Inc/BC
Option (Right to Buy Common Shares)
A - Award 75,000 75,000
2017-10-13 2017-10-11 4 XBIO Xenetic Biosciences, Inc.
Stock Option
A - Award 6,250 25,000 33.33
2017-10-13 2017-10-11 4 XBIO Xenetic Biosciences, Inc.
Stock Option
A - Award 6,250 25,000 33.33
2017-10-13 2017-10-11 4 XBIO Xenetic Biosciences, Inc.
Stock Option
A - Award 6,250 18,750 50.00
2017-10-13 2017-10-11 4 XBIO Xenetic Biosciences, Inc.
Stock Option
A - Award 6,250 12,500 100.00
2017-09-18 2017-09-15 4 OPK Opko Health, Inc.
Common Stock
P - Purchase 1,500 162,793 0.93 6.03 9,045 981,642
2017-08-22 3 XBIO Xenetic Biosciences, Inc.
Common Stock
0
2017-06-16 2017-06-14 4 VBIV VBI Vaccines Inc/BC
Restricted Stock Units (RSUs)
M - Exercise -12,500 25,000 -33.33
2017-06-16 2017-06-14 4 VBIV VBI Vaccines Inc/BC
Common Shares, no par value per share
M - Exercise 12,500 25,000 100.00
2017-03-31 2017-03-30 4 VBIV VBI Vaccines Inc/BC
Option (Right to Buy Common Shares)
A - Award 12,500 12,500
2017-03-31 3 VBIV VBI Vaccines Inc/BC
Common Shares, no par value per share
25,000
2017-03-31 3 VBIV VBI Vaccines Inc/BC
Common Shares, no par value per share
25,000
2017-03-15 2017-03-14 4 OPK Opko Health, Inc.
Common Stock
S - Sale -112,975 161,293 -41.19 8.07 -911,674 1,301,586
2017-03-15 2017-03-13 4 OPK Opko Health, Inc.
Stock Option (Right to Buy)
M - Exercise -75,000 0 -100.00
2017-03-15 2017-03-13 4 OPK Opko Health, Inc.
Stock Option (Right to Buy)
M - Exercise -189,207 0 -100.00
2017-03-15 2017-03-13 4 OPK Opko Health, Inc.
Common Stock
F - Taxes -35,728 274,268 -11.53 7.92 -282,966 2,172,203
2017-03-15 2017-03-13 4 OPK Opko Health, Inc.
Common Stock
M - Exercise 75,000 309,996 31.92 2.36 177,000 731,591
2017-03-15 2017-03-13 4 OPK Opko Health, Inc.
Common Stock
M - Exercise 189,207 234,996 413.21 0.56 105,956 131,598
2016-04-01 2016-04-01 4 OPK Opko Health, Inc.
Stock Option (Right to Buy)
A - Award 250,000 250,000
2015-09-15 2015-09-14 4 OPK Opko Health, Inc.
Common Stock
P - Purchase 900 45,789 2.00 9.95 8,955 455,601
2015-09-15 2015-09-14 4 OPK Opko Health, Inc.
Common Stock
P - Purchase 100 44,889 0.22 9.94 994 446,421
2015-03-19 2015-03-18 4 OPK Opko Health, Inc.
Stock Option (Right to Buy)
A - Award 250,000 250,000
2015-03-13 2015-03-13 4 OPK Opko Health, Inc.
Common Stock
S - Sale -1,500 44,789 -3.24 14.64 -21,968 655,935
2015-03-13 2015-03-13 4 OPK Opko Health, Inc.
Common Stock
S - Sale -38,888 46,289 -45.66 14.64 -569,320 677,671
2015-03-13 2015-03-13 4 OPK Opko Health, Inc.
Common Stock
S - Sale -500 85,177 -0.58 14.62 -7,308 1,244,862
2015-03-13 2015-03-13 4 OPK Opko Health, Inc.
Common Stock
S - Sale -576 85,677 -0.67 14.61 -8,415 1,251,741
2015-03-13 2015-03-13 4 OPK Opko Health, Inc.
Common Stock
S - Sale -24 86,253 -0.03 14.56 -349 1,255,844
2015-03-13 2015-03-12 4 OPK Opko Health, Inc.
Stock Option (Right to Buy)
M - Exercise -35,000 0 -100.00
2015-03-13 2015-03-12 4 OPK Opko Health, Inc.
Stock Option (Right to Buy)
M - Exercise -60,000 0 -100.00
2015-03-13 2015-03-12 4 OPK Opko Health, Inc.
Common Stock
F - Taxes -3,956 86,277 -4.38 14.60 -57,758 1,259,644
2015-03-13 2015-03-12 4 OPK Opko Health, Inc.
Common Stock
M - Exercise 35,000 90,233 63.37 1.65 57,750 148,884
2015-03-13 2015-03-12 4 OPK Opko Health, Inc.
Common Stock
F - Taxes -4,767 55,233 -7.94 14.60 -69,598 806,402
2015-03-13 2015-03-12 4 OPK Opko Health, Inc.
Common Stock
M - Exercise 60,000 60,000 1.16 69,600 69,600
2014-04-15 2014-04-14 4 OPK Opko Health, Inc.
Stock Option (Right to Buy)
A - Award 250,000 250,000
2013-03-20 2013-03-18 4 OPK Opko Health, Inc.
Stock Option (Right to Buy)
A - Award 125,000 125,000
2013-02-05 2013-02-01 4 OPK Opko Health, Inc.
Stock Option (Right to Buy)
M - Exercise -50,000 189,207 -20.90
2013-02-05 2013-02-01 4 OPK Opko Health, Inc.
Common Stock
S - Sale -20,000 0 -100.00 6.74 -134,800
2013-02-05 2013-02-01 4 OPK Opko Health, Inc.
Common Stock
S - Sale -20,000 20,000 -50.00 6.71 -134,200 134,200
2013-02-05 2013-02-01 4 OPK Opko Health, Inc.
Common Stock
S - Sale -10,000 40,000 -20.00 6.70 -67,000 268,000
2013-02-05 2013-02-01 4 OPK Opko Health, Inc.
Common Stock
M - Exercise 50,000 50,000 0.56 28,000 28,000
2006-03-15 3/A NABI NABI BIOPHARMACEUTICALS
Common Stock
9,334
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)